Lipitor Lawsuits on the Rise
Several news outlets are reporting that Pfizer, a top pharmaceutical company, may be facing a surge of lawsuits in the near future.
The lawsuits are being filed by women who allege the company was aware of serious side effects associated with the anti-cholesterol drug Lipitor but failed to accurately warn the public of the dangers.
About the Lipitor Lawsuits
Reuters reports that within the past five months, the number of federal court filings introducing lawsuits by U.S. women who claim that taking Lipitor gave them type-2 diabetes has drastically increased from 56 to almost 1,000.
The onslaught of lawsuits was brought on by an announcement by the Food and Drug Administration (FDA) in 2012 that treatment with Lipitor is associated with incidents of memory loss and an increased risk of diabetes.
According to lawyers representing the women, there are higher instances of women developing diabetes from using Lipitor while gaining fewer benefits than men using Lipitor.
Lipitor Lawsuit Consolidated
Another reason for the recent increase in lawsuits is a result of a decision by a federal judicial panel to consolidate all Lipitor diabetes lawsuits from around the country into a single Federal courtroom in Charleston, South Carolina.
Pfizer rallied against the consolidation, due to their concern of it creating copycat filings. The first case is scheduled to be tried next July.
Pfizer is denying any liability and intends to actively fight the lawsuits.